🇺🇸 FDA
Patent

US 8759318

Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

granted A61PA61P1/16A61P31/12

Quick answer

US patent 8759318 (Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections) held by University College Cardiff Consultants Limited expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
78
CPC classes
A61P, A61P1/16, A61P31/12, A61P31/14